Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series. Cancer. 2020 02 01; 126(3):523-530.